Price Alert

BioLineRx Ltd. (BLRX)

NASDAQ: BLRX · Real-Time Price · USD

3.75

-0.02 (-0.53%)

At close: Aug 15, 2025, 3:59 PM

3.77

0.53%

After-hours: Aug 15, 2025, 07:16 PM EDT

BioLineRx Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	9.04M	10.44M	8.84M	9.62M	5.99M	4.25M	7.73M	10.1M	9.07M	10.59M	13.11M	14M	11.45M	12.99M	14.08M	17.48M	16.05M
Short-Term Investments	17.33M	9.13M	20.34M	30.44M	22.18M	38.74M	18.24M	22.71M	34.22M	40.49M	44.16M	29.15M	39.14M	44.15M	48.13M	48.08M	42.04M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	1.92M	3.86M	3.96M	3.83M	3.34M	708K	315K	128K	302K	721K	143K	240K	190K	142K	192K	668K	190K
Inventory	3.31M	3.15M	3.54M	3.63M	2.89M	1.95M	1.35M	n/a	n/a	197.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	480K	n/a	n/a	n/a	-197.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	31.92M	27.1M	37.85M	49.11M	35.69M	47.18M	28.8M	34.69M	44.33M	52M	57.94M	44.1M	50.94M	57.4M	62.85M	67.07M	59.35M
Property-Plant & Equipment	1.16M	1.35M	1.65M	1.8M	1.72M	1.89M	2.02M	2.23M	2.36M	2.5M	2.02M	2.03M	2.13M	2.28M	2.35M	2.55M	2.54M
Goodwill & Intangibles	10.43M	10.45M	13.25M	13.69M	14.19M	14.85M	22.03M	22.01M	21.96M	21.89M	21.72M	21.7M	21.7M	21.7M	21.7M	21.71M	21.71M
Total Long-Term Assets	11.59M	11.8M	14.89M	15.49M	15.91M	16.74M	24.05M	24.24M	24.32M	24.38M	23.73M	23.73M	23.83M	23.99M	24.06M	24.26M	24.25M
Total Assets	43.51M	38.91M	52.74M	64.6M	51.6M	63.92M	52.85M	58.94M	68.65M	76.38M	81.67M	67.84M	74.77M	81.39M	86.91M	91.33M	83.6M
Account Payables	4.69M	5.58M	4.63M	6.27M	8.26M	10.87M	8.44M	6.73M	7.14M	6.97M	5.83M	7.34M	5.78M	5.57M	5.44M	5.32M	5.76M
Deferred Revenue	n/a	n/a	2.25M	n/a	9.03M	12.96M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	4.68M	4.48M	9.82M	10.66M	3.68M	3.15M	3.08M	3.08M	2.56M	1.54M	802K	1.01M	1.9M	2.76M	3.58M	3.35M	3.22M
Other Current Liabilities	2.46M	2.12M	4.37M	13.09M	7.49M	12.02M	n/a	n/a	n/a	84K	n/a	n/a	n/a	2K	n/a	n/a	n/a
Total Current Liabilities	14.03M	15.41M	24.96M	30.52M	31.37M	42.78M	14.72M	12.45M	12.04M	10.68M	8.13M	9.63M	9.1M	9.72M	10.31M	9.92M	10.22M
Long-Term Debt	7.63M	8.96M	17.98M	18.79M	5.94M	6.63M	8.46M	8.49M	8.24M	8.63M	8.35M	n/a	n/a	n/a	n/a	1.01M	1.89M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	11.93M	15.29M	15.35M	7.55M	4.51M	8.16M	186K	604K	1.86M	4.01M	4.81M	5.25M
Total Long-Term Liabilities	8.62M	10.04M	19.27M	20.1M	7.17M	19.85M	25M	25.44M	17.49M	14.86M	18.02M	1.64M	2.26M	3.58M	5.69M	7.52M	8.74M
Total Liabilities	22.65M	25.45M	44.24M	50.62M	38.54M	50.7M	39.72M	37.88M	29.53M	25.54M	26.15M	11.27M	11.36M	13.3M	16M	17.44M	18.95M
Total Debt	13.74M	15.04M	29.61M	31.25M	11.31M	11.59M	13.31M	13.54M	12.88M	12.32M	10.81M	2.61M	3.71M	4.65M	5.42M	6.24M	6.85M
Common Stock	62.57M	38.1M	34.43M	34.41M	31.36M	31.36M	28.33M	27.1M	27.1M	27.1M	27.1M	21.16M	21.07M	21.07M	20.87M	20.5M	18.73M
Retained Earnings	-394.7M	-399.83M	-396.64M	-390.82M	-391.3M	-390.61M	-376.72M	-360.7M	-342.15M	-329.99M	-324.26M	-317.41M	-309.97M	-305.04M	-300.74M	-295.02M	-288.18M
Comprehensive Income	15.68M	16.13M	16.3M	17.96M	17.52M	16.99M	16.06M	15.61M	15.13M	14.76M	13.85M	13.15M	12.87M	12.72M	12.71M	12.53M	12.17M
Shareholders Equity	20.86M	13.46M	8.51M	13.98M	13.06M	13.22M	13.13M	21.05M	39.11M	50.84M	55.52M	56.57M	63.41M	68.09M	70.9M	73.89M	64.65M
Total Investments	17.33M	9.13M	20.34M	30.44M	22.18M	38.74M	18.24M	22.71M	34.22M	40.49M	44.16M	29.15M	39.14M	44.15M	48.13M	48.08M	42.04M